Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Therapie|March 2, 2020
Patients' organizations in rare diseases and involvement in drug information: Illustrations with LMC France, the French Association of Chronic Myeloid leukemiaMina Daban, Clémence Lacroix, Joëlle Micallef
Therapie|March 2, 2020
Pharmacovigilance and drug-induced rare diseases: Strengths of the French Network of Regional Pharmacovigilance CentresClémence Lacroix, Michel Mallaret, Annie-Pierre Jonville-Bera
Therapie|June 9, 2023
Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolboxClémence Lacroix, Romain Guilhaumou, Joëlle Micallef, et al.
Therapie|November 8, 2024
Monitoring misuse and abuse of psychoactive substances in France: Insights from substance abuse treatment facilities through the OPPIDUM programClémence Lacroix, Elisabeth Frauger, Elisabeth Jouve, et al.
Frontiers in Psychiatry|June 3, 2021
Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance NetworkThomas Soeiro, Clémence Lacroix, Vincent Pradel, et al.
Fundamental & Clinical Pharmacology|December 13, 2025
Use of Psychoactive Substances Before Incarceration Among Prison Inmates With Drug Abuse or Dependence: Data From the OPPIDUM ProgramZeinab Abbas, Clémence Lacroix, Elisabeth Jouve, et al.
Fundamental & Clinical Pharmacology|March 26, 2026
Factors Associated With Cocaine Use Disorder: Results From the French Nationwide Repeated Cross-Sectional OPPIDUM Study (2019-2023)Zenab Alhamidi, Clémence Lacroix, Elisabeth Jouve, et al.
Therapie|May 22, 2022
[Increasing methylphenidate abuse: Tracking and profiles during 13-years]Clémence Guerra, Thomas Soeiro, Clémence Lacroix, et al.
British Journal of Clinical Pharmacology|October 16, 2025
Psychoactive prescription drug use and misuse in patients on opioid agonist treatmentThomas Soeiro, Clémence Lacroix, Élisabeth Jouve, et al.
Therapie|May 14, 2022
Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemicPauline Lory, Jeffrey Lombardi, Clémence Lacroix, et al.
Pageof 3